Related Experiment Video
Updated: Apr 20, 2026

Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles
Published on: June 8, 2012
Studies on mitogen-activated protein kinase signaling pathway in the alveolar macrophages of chronic bronchitis rats
Yan Huang1, Xiao-Ming Meng, Guo-Lin Jiang
1School of Pharmacy, Anhui Medical University, Tunxi West Road, Hefei, 230032, Anhui, China.
Abstract:
Lipopolysaccharide (LPS), a potent stimulator of inflammatory responses in alveolar macrophages (AMs), activates several intracellular signaling pathways, including mitogen-activated protein kinases (MAPK). In the present study, we investigated the MAPK pathway in AMs of chronic bronchitis (CB) rats. CB was induced by endotracheal instillation of LPS followed by Bacillus Calmette Guerin injection through the caudal vein 1 week later. Specific inhibitors were used and protein phosphorylations were detected by Western blot. We found that Genistein (PTK inhibitor) could inhibit protein kinase C (PKC), phosphatidylinositol-3 kinase (PI3K)/protein kinase B (Akt or PKB) MAPK signaling pathway with different degrees, LY294002 (PI3K inhibitor) could not only inhibit phospho-PI3K/Akt expression, but also inhibit p38 and c-Jun NH2-terminal kinases (JNK) phosphorylation. Calphostin C (PKC inhibitor) could inhibit phospho-PKC expression and exerted significant effects on extracellular signal-regulated kinases (ERK) phosphorylation, however, it had no impact on p38 and JNK phosphorylation. These results demonstrated that the LPS mediated signaling pathway of MAPK in AMs of CB rats could be described as follows: PTK-PI3K-Akt-JNK/p38 or PTK-PI3K-PKC-ERK, and PI3K may have a negative regulation on the activation of downstream proteins.
Insights
Lipopolysaccharide (LPS) activates mitogen-activated protein kinases (MAPK) in chronic bronchitis (CB) rats. PI3K signaling negatively regulates downstream proteins in LPS-stimulated alveolar macrophages (AMs).
Area of Science:
- Cell Biology
- Immunology
- Respiratory Medicine
Background:
- Lipopolysaccharide (LPS) triggers inflammatory responses in alveolar macrophages (AMs) via intracellular signaling pathways like mitogen-activated protein kinases (MAPK).
- Chronic bronchitis (CB) is characterized by persistent airway inflammation, involving complex signaling cascades within AMs.
Purpose of the Study:
- To investigate the specific mitogen-activated protein kinase (MAPK) signaling pathway activated by LPS in AMs of CB rats.
- To elucidate the roles of protein tyrosine kinase (PTK), phosphatidylinositol-3 kinase (PI3K), protein kinase C (PKC), and their downstream effectors in this pathway.
Main Methods:
- Chronic bronchitis (CB) was induced in rats using LPS and Bacillus Calmette Guerin.
- Specific pathway inhibitors (Genistein, LY294002, Calphostin C) were administered.
- Protein phosphorylation levels were quantified using Western blot analysis.
Main Results:
- Genistein inhibited protein kinase C (PKC), PI3K/protein kinase B (Akt) signaling.
- LY294002 inhibited phospho-PI3K/Akt, p38, and c-Jun NH2-terminal kinases (JNK) phosphorylation.
- Calphostin C inhibited phospho-PKC and extracellular signal-regulated kinases (ERK) phosphorylation but not p38 or JNK.
Conclusions:
- The LPS-mediated MAPK pathway in CB rat AMs involves PTK-PI3K-Akt-JNK/p38 or PTK-PI3K-PKC-ERK signaling.
- Phosphatidylinositol-3 kinase (PI3K) appears to exert negative regulation on the activation of downstream signaling proteins.
Related Concept Videos
MAPK Signaling Cascades
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
